Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation

Published:2009-12 Issue:1 Volume:390 Page:48-53
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Sugimoto Takumi,Tomita Akihiro,Hiraga Junji,Shimada Kazuyuki,Kiyoi Hitoshi,Kinoshita Tomohiro,Naoe Tomoki

Funder

Ministry of Health, Labor and Welfare

National Institute of Biomedical Innovation

Ministry of Education, Culture, Sports, Science and Technology, Japan

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference30 articles.

1. Monoclonal antibody therapy for B-cell malignancies;Cheson;Semin. Oncol.,2006

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N. Engl. J. Med.,2002

3. Monoclonal antibody therapy for B-cell non-Hodgkin’s lymphoma;Cheson;N. Engl. J. Med.,2008

4. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance;Smith;Oncogene,2003

5. Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels;Czuczman;Clin. Cancer Res.,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy;Virchows Archiv;2024-02-13

2. Mechanisms of resistance to anti-CD20 antibodies in lymphoid malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

3. Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway;Chinese Medical Journal;2023-04-28

4. CD20, generalidades básicas-moleculares y su posible relación como marcador de mal pronóstico en leucemia;Revista Colombiana de Cancerología;2023-03-30

5. NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia;Frontiers in Oncology;2022-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3